Filing Details

Accession Number:
0001209191-18-025379
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-04-18 16:38:17
Reporting Period:
2018-04-16
Accepted Time:
2018-04-18 16:38:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
831547 Spectrum Pharmaceuticals Inc SPPI Pharmaceutical Preparations (2834) 930979187
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1193918 Md C Rajesh Shrotriya 11500 S. Eastern Ave.
Suite 240
Henderson NV 89052
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Disposition 2018-04-16 30,000 $18.72 1,209,977 No 4 S Indirect By CS Family Trust
Common Stock, $0.001 Par Value Disposition 2018-04-17 30,000 $18.56 1,179,977 No 4 S Indirect By CS Family Trust
Common Stock, $0.001 Par Value Disposition 2018-04-18 30,000 $19.71 1,149,977 No 4 S Indirect By CS Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By CS Family Trust
No 4 S Indirect By CS Family Trust
No 4 S Indirect By CS Family Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.001 Par Value 1,787,542 Indirect By Shrotriya Gift Trust
Common Stock, $0.001 Par Value 1,243,284 Indirect By RS Irrevocable Trust
Common Stock, $0.001 Par Value 28,907 Indirect By 401(k) Plan
Common Stock, $0.001 Par Value 9,523 Indirect By Spouse
Common Stock, $0.001 Par Value 67,144 Indirect By Shrotriya Family Foundation
Common Stock, $0.001 Par Value 200,652 Direct
Footnotes
  1. All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 19, 2018.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.41 to $19.20, inclusive. The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.49 to $18.62, inclusive. The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.51 to $20.08, inclusive. The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.